AAP
Ardsley Advisory Partners’s Aldeyra Therapeutics ALDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.85M | Buy |
2,050,000
+300,000
| +17% | +$1.15M | 1.03% | 25 |
|
|
2025
Q1 | $9.89M | Buy |
1,750,000
+600,000
| +52% | +$3.39M | 1.89% | 8 |
|
|
2024
Q4 | $5.74M | Buy |
1,150,000
+650,000
| +130% | +$3.24M | 0.91% | 36 |
|
|
2024
Q3 | $2.7M | Buy |
+500,000
| New | +$2.7M | 0.44% | 61 |
|
|
2020
Q4 | – | Sell |
-62,100
| Closed | -$460K | – | 107 |
|
|
2020
Q3 | $460K | Hold |
62,100
| – | – | 0.09% | 83 |
|
|
2020
Q2 | $259K | Buy |
62,100
+25,000
| +67% | +$104K | 0.06% | 99 |
|
|
2020
Q1 | $92K | Hold |
37,100
| – | – | 0.04% | 80 |
|
|
2019
Q4 | $216K | Sell |
37,100
-10,000
| -21% | -$58.2K | 0.03% | 110 |
|
|
2019
Q3 | $248K | Hold |
47,100
| – | – | 0.06% | 91 |
|
|
2019
Q2 | $282K | Sell |
47,100
-5,000
| -10% | -$29.9K | 0.04% | 99 |
|
|
2019
Q1 | $470K | Hold |
52,100
| – | – | 0.09% | 74 |
|
|
2018
Q4 | $432K | Sell |
52,100
-2,900
| -5% | -$24K | 0.11% | 64 |
|
|
2018
Q3 | $759K | Buy |
55,000
+10,000
| +22% | +$138K | 0.1% | 67 |
|
|
2018
Q2 | $358K | Hold |
45,000
| – | – | 0.05% | 114 |
|
|
2018
Q1 | $336K | Hold |
45,000
| – | – | 0.05% | 111 |
|
|
2017
Q4 | $306K | Buy |
45,000
+5,448
| +14% | +$37K | 0.04% | 100 |
|
|
2017
Q3 | $285K | Buy |
39,552
+25,000
| +172% | +$180K | 0.04% | 100 |
|
|
2017
Q2 | $68K | Buy |
+14,552
| New | +$68K | 0.01% | 115 |
|